Retraction: Nuclear Factor-κB p65 Mediates Tumor Necrosis Factor α-induced Nuclear Translocation of Telomerase Reverse Transcriptase Protein [0.03%]
撤稿报告:核转录因子-κB p65介导的肿瘤坏死因子α诱导的端粒酶逆转录酶蛋白核转运
Masaharu Akiyama,Teru Hideshima,Toshiaki Hayashi et al.
Masaharu Akiyama et al.
Retraction of Publication
Cancer research. 2024 Mar 15;84(6):939. DOI:10.1158/0008-5472.CAN-24-0517 2024
A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma [0.03%]
一种Benzarone衍生物通过抑制EYA来抑制SHH髓母细胞瘤中的肿瘤生长
Grace H Hwang,Maria F Pazyra-Murphy,Hyuk-Soo Seo et al.
Grace H Hwang et al.
Medulloblastoma is one of the most common malignant brain tumors of children, and 30% of medulloblastomas are driven by gain-of-function genetic lesions in the Sonic Hedgehog (SHH) signaling pathway. EYA1, a haloacid dehalogenase phosphatas...
FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma [0.03%]
FASN抑制降低MHC-I降解并协同PD-L1检点阻断在肝细胞性 carcinoma中的作用
Jiao Huang,Wai Ying Tsang,Xiao-Na Fang et al.
Jiao Huang et al.
Immune checkpoint inhibitors (ICI) transformed the treatment landscape of hepatocellular carcinoma (HCC). Unfortunately, patients with attenuated MHC-I expression remain refractory to ICIs, and druggable targets for upregulating MHC-I are l...
Retraction: Insulin-like Growth Factor-1 Induces Adhesion and Migration in Human Multiple Myeloma Cells via Activation of β1-Integrin and Phosphatidylinositol 3'-Kinase/AKT Signaling [0.03%]
撤消:胰岛素样生长因子-1通过活化β1-整合素和磷脂酰肌醇3激酶/AKT信号传导诱导人体多发性骨髓瘤细胞粘附与迁移
Yu-Tzu Tai,Klaus Podar,Laurence Catley et al.
Yu-Tzu Tai et al.
Retraction of Publication
Cancer research. 2024 Mar 15;84(6):938. DOI:10.1158/0008-5472.CAN-24-0519 2024
Retraction: Effects of Oligonucleotide N3'→P5' Thio-phosphoramidate (GRN163) Targeting Telomerase RNA in Human Multiple Myeloma Cells [0.03%]
撤回通告:针对人多发性骨髓瘤细胞中的端粒酶RNA的寡核苷酸N3'→P5'硫代磷酸酰胺(格瑞163)的作用
Masaharu Akiyama,Teru Hideshima,Masood A Shammas et al.
Masaharu Akiyama et al.
Retraction of Publication
Cancer research. 2024 Mar 15;84(6):937. DOI:10.1158/0008-5472.CAN-24-0518 2024
Retraction: Cytokines Modulate Telomerase Activity in a Human Multiple Myeloma Cell Line [0.03%]
撤消:细胞因子调节人多发性骨髓瘤细胞系的端粒酶活性
Masaharu Akiyama,Teru Hideshima,Toshiaki Hayashi et al.
Masaharu Akiyama et al.
Retraction of Publication
Cancer research. 2024 Mar 15;84(6):940. DOI:10.1158/0008-5472.CAN-24-0516 2024
AKTing on R Loops Makes for an ATRactive Target in Ovarian Cancer Therapy [0.03%]
在卵巢癌治疗中,作用于R环的Akt和ATR形成了一个极具吸引力的靶点组合
Vijayalalitha Ramanarayanan,Philipp Oberdoerffer
Vijayalalitha Ramanarayanan
High-grade serous ovarian carcinoma (HGSOC) is the deadliest subtype of ovarian cancer. While PARP inhibitors (PARPi) have transformed the care of advanced HGSOC, PARPi resistance poses a major limitation to their clinical utility. DNA dama...
Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy [0.03%]
通过靶向SLAMF7调节的CCL2信号恢复免疫抑制性巨噬细胞的极化使肝细胞癌对免疫治疗敏感
Jialei Weng,Zheng Wang,Zhiqiu Hu et al.
Jialei Weng et al.
Immune checkpoint inhibitors have limited efficacy in hepatocellular carcinoma (HCC). Macrophages are the most abundant immune cells in HCC, suggesting that a better understanding of the intrinsic processes by which tumor cells regulate mac...
FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA [0.03%]
FUME-TCRseq可实现从有限降解RNA中灵敏准确地测序T细胞受体
Ann-Marie Baker,Gayathri Nageswaran,Pablo Nenclares et al.
Ann-Marie Baker et al.
Genomic analysis of the T-cell receptor (TCR) reveals the strength, breadth, and clonal dynamics of the adaptive immune response to pathogens or cancer. The diversity of the TCR repertoire, however, means that sequencing is technically chal...
A Histone Methylation-MAPK Signaling Axis Drives Durable Epithelial-Mesenchymal Transition in Hypoxic Pancreatic Cancer [0.03%]
缺氧胰腺癌中组蛋白甲基化-MAPK信号轴驱动上皮-间充质转化持久化
Brooke A Brown,Paul J Myers,Sara J Adair et al.
Brooke A Brown et al.
The tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC) plays a key role in tumor progression and response to therapy. The dense PDAC stroma causes hypovascularity, which leads to hypoxia. Here, we showed that hypoxia drives l...